Mechanism: A timed leucine pulse during the active phase, combined with caloric restriction, transiently activates mTORC1 to initiate autophagy, followed by fasting-induced mTORC1 inhibition for degradation. Readout: Readout: This 'pulse-fast' cycle significantly increases autophagic flux, enhances EV-LC3B biomarker levels, and improves metabolic health and immune function.
Hypothesis
Circadian‑aligned, leucine‑rich protein pulses administered during the active phase amplify autophagy flux in the context of moderate caloric restriction (CR), and circulating extracellular vesicle‑associated LC3B serves as a non‑invasive biomarker of this enhanced flux.
Rationale
Prolonged fasting and CR activate autophagy via mTORC1 inhibition and AMPK activation [2]. Yet autophagy is a dynamic process that requires both initiation and completion phases. Recent work shows that time‑of‑day feeding dramatically influences lifespan benefits in mice, with active‑phase feeding yielding a 35 % lifespan extension versus 10 % for constant CR [3]. This suggests that the circadian regulation of nutrient‑sensing pathways gates autophagy efficiency.
We propose that a brief, leucine‑rich protein pulse at the start of the active phase transiently activates mTORC1, promoting phagophore nucleation and LC3‑II lipidation. The ensuing fasting period then allows mTORC1 inhibition, driving autophagosome maturation and lysosomal degradation. This "pulse‑fast" cycle could therefore increase net autophagic flux beyond that achieved by steady CR alone, while preserving muscle mass and immune function—addressing the observation that the longest‑lived CR mice maintained weight and immunity [4].
Testable Predictions
- Flux Increase – In human volunteers undergoing a 15 % CR diet, those receiving a 10 g leucine‑rich whey pulse at wake‑time will show a greater increase in autophagic flux markers (e.g., SQSTM1/p62 decline, LC3‑II turnover after lysosomal inhibition) compared with iso‑caloric CR without the pulse.
- Biomarker Validity – Concentrations of LC3B‑positive extracellular vesicles isolated from plasma will correlate positively with flux measurements obtained from peripheral blood mononuclear cells (PBMCs) after ex‑ lysosomal inhibition, and will fluctuate in synchrony with the pulse‑fast schedule.
- Functional Outcome – Participants adhering to the pulse‑fast CR regimen will exhibit improved insulin sensitivity and preserved NK‑cell activity relative to standard CR, indicating that metabolic benefits are not achieved at the expense of immunity.
Experimental Design
- Population: 60 healthy adults aged 30‑50, BMI 25‑30, randomized to three groups (n=20 each): (A) 15 % CR with active‑phase leucine pulse, (B) 15 % CR iso‑caloric control, (C) weight‑maintenance diet.
- Intervention: Group A receives 10 g whey protein (≈2.5 g leucine) within 30 min of waking; groups B and C receive an isocaloric carbohydrate snack.
- Measurements: Baseline and weekly fasting blood draws for PBMC autophagy flux (LC3‑II/I ratio with bafilomycin A1), plasma EV‑LC3B (via ELISA on CD63‑positive vesicles), glucose, insulin, cytokine panel, and VO₂ max. Subjective wellbeing and physical activity logs collected.
- Analysis: Mixed‑effects models to test group × time interactions for flux and biomarker levels; mediation analysis to assess whether EV‑LC3B changes mediate the effect of the pulse on metabolic outcomes.
Mechanistic Insight
The hypothesis integrates circadian biology with the concept of "autophagy priming". A transient mTORC1 activation supplies the necessary phospholipid membranes and ATG protein recruitment for phagophore formation, while the subsequent fasting period ensures that these structures proceed to degradation rather than stalling. This mirrors the natural feeding‑fasting cycle observed in nocturnal mammals, where nutrient spikes at activity onset coincide with heightened lysosomal biogenesis. By aligning protein intake with the active phase, we exploit endogenous circadian peaks in TFEB expression and lysosomal acidification, thereby enhancing the clearance step of autophagy.
If validated, this approach would provide a practical, personalized strategy to maximize the longevity‑promoting effects of CR while offering a readily accessible biomarker (EV‑LC3B) to monitor autophagic response in real time—addressing the current lack of direct flux measurements in human fasting studies [5].
Falsifiability
If the leucine‑rich pulse fails to produce a statistically significant increase in either autophagic flux markers or EV‑LC3B levels compared with control CR, or if no improvement in metabolic or immune parameters is observed, the hypothesis would be refuted. Conversely, a positive result would support the model that timed nutrient pulses can gate autophagy efficiency and that circulating EV‑LC3B reflects this process.
Comments
Sign in to comment.